Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

about

Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

Item

http://www.wikidata.org/entity/Q50134501

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

@en

type

Item

label

Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

@en

prefLabel

Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

@en

P1476

Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis

@en

P2093

Balazs Tamas Nemeth

http://www.w3.org/2001/XMLSchema#string

Bernd Schnabl

http://www.w3.org/2001/XMLSchema#string

Bin Gao

http://www.w3.org/2001/XMLSchema#string

Dechun Feng

http://www.w3.org/2001/XMLSchema#string

Evangelos Dioletis

http://www.w3.org/2001/XMLSchema#string

Fu-Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Ji-Yuan Zhang

http://www.w3.org/2001/XMLSchema#string

Joan Caballeria

http://www.w3.org/2001/XMLSchema#string

Natalie Julia Torok

http://www.w3.org/2001/XMLSchema#string

Peter Stärkel

http://www.w3.org/2001/XMLSchema#string

P2860

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

Hypoxia-inducible factors and the response to hypoxic stress

Hypoxia-inducible factors as molecular targets for liver diseases

The Role of Oxidative Stress and Antioxidants in Liver Diseases

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

Reactive oxygen species in inflammation and tissue injury

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.

Epidemiology and natural history of non-alcoholic fatty liver disease.

P304

339-350.e3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2018.01.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pal Pacher

Joaquín Cabezas

Irma Garcia-Martinez

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29414684

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

digoxin

P932

5806149

http://www.w3.org/2001/XMLSchema#string